- To stay updated on the relevant developments, make sure you are signed up for our newsletter.
-
The enduring materials of the Innovations in HIV Therapeutics 2022 - Asia-Pacific Edition are available here.
Topics
Meeting category
Date(s)
15 Aug 2023
Program Language
English, Mandarin
Meeting type
Virtual Meeting
Organizer
Innovations in HIV Therapeutics 2023 - Asia-Pacific Edition
Related Enduring Materials
Enduring Materials
Tuesday, 15 August 2023
Session 2: Management Considerations -
Pharmacological Considerations: Different Modes of Delivery / Stopping / DDI's
Practical & Clinical Considerations of implementing LA ART
Session 3: Optimal Treatment in Key Populations -
Treatment Considerations in Cisgender/Transgender Women (Pregnancy / Breastfeeding / Hormonal Interactions)
Managing Antiretroviral Treatment Failure
Overview
What's New
About this Program
The Innovations in HIV Therapeutics 2023 - Asia-Pacific Edition took place as a virtual meeting on 15 August 2023.
As the pipeline of HIV drugs continues to evolve and novel formulations and devices are on the horizon, the Innovation in HIV Therapeutics meeting provides a scientific program that keeps HIV-treating clinicians, pharmacologists, and virologists updated on the latest data present in preclinical and early clinical development. New formulations, novel compounds, and their modes of action will be presented, as well as their pharmacological properties, potential drug-drug interactions, and possible toxicities.
This meeting was a one-day program accounting for the unique regional differences present in the Asia Pacific region.
Program Director
General Information
Who Should Attend?
- HIV-treating Clinicians
- Pharmacologists
- Virologists
- Researchers
- Pharmacologists
- Virologists
- Researchers
Meeting Objectives
This meeting aims to:
- Update clinicians on the latest therapeutics and innovations in HIV (long-acting) therapeutics;
- Understand pharmacological properties, safety profile, and resistance of new long-acting ART;
- Evaluate how innovations in treatments can impact people living with HIV.
- Update clinicians on the latest therapeutics and innovations in HIV (long-acting) therapeutics;
- Understand pharmacological properties, safety profile, and resistance of new long-acting ART;
- Evaluate how innovations in treatments can impact people living with HIV.
Learning Objectives
After participating in this activity, participants will be able to:
- Describe the innovations in HIV treatments, novel formulations and devices on the horizon;
- Define pharmacological properties, potential drug-drug interactions, possible toxicities, and resistance profiles of novel drugs;
- Reflect on the implementation of novel HIV (long-acting) therapeutics in various populations and settings.
- Describe the innovations in HIV treatments, novel formulations and devices on the horizon;
- Define pharmacological properties, potential drug-drug interactions, possible toxicities, and resistance profiles of novel drugs;
- Reflect on the implementation of novel HIV (long-acting) therapeutics in various populations and settings.
Practical Information
Certificate of Attendance
A certificate of attendance will be sent to participants after they successfully complete the program and post-meeting survey.
Language
The official language of the meeting is English.
Enduring Materials
A recording of the full program will be available within 3 weeks after the meeting on the virtual platform. After 3 weeks, provided we have the speakers' permission, the materials will be available on the meeting website.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees
Program Director
Support
Support
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in innovations in HIV therapeutics in the Asia-Pacific region.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause, get in touch with us for a tailored support package by contacting Rikke Puggaard-Rode at Rikke.Rode@amededu.com.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
Endorsers
The Innovations in HIV Therapeutics 2023 - Asia Pacific Edition is endorsed by the following societies and organizations. Their support and collaboration are key to the success of this forum.
If you would like your organization to endorse this forum, please contact Andrés Ma at yuxuan.ma@amededu.com
Previous Editions
Previous Edition
1st Edition - Innovations in HIV Therapeutics 2022 - Asia-Pacific Edition, Virtual (link)
Language
Related Programs
